Vergoeding 2017-2021 voor ATC-subgroep N06AA : Niet-selectieve monoamine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| N06AA02 Imipramine | 169.940 | 145.980 | 141.350 | 159.930 | 404.600 |
| N06AA04 Clomipramine | 1.115.400 | 1.136.000 | 1.158.700 | 1.150.900 | 1.136.500 |
| N06AA09 Amitriptyline | 2.093.800 | 2.343.600 | 2.803.100 | 2.963.100 | 2.813.200 |
| N06AA10 Nortriptyline (Nortrilen ®) | 3.684.000 | 3.847.000 | 3.755.800 | 3.544.300 | 3.631.800 |
| N06AA12 Doxepine | 95.038 | 91.149 | 82.811 | 20.812 | 274 |
| N06AA16 Dosulepine (Prothiaden ®) | 54.093 | 47.055 | 45.838 | 53.372 | 55.522 |
| N06AA21 Maprotiline | 64.790 | 60.317 | 50.288 | 64.938 | 66.416 |
| Totaal | 7.277.061 | 7.671.101 | 8.037.887 | 7.957.352 | 8.108.312 |